These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11925798)

  • 1. [Arguments for offering triple test serum screening for Down's syndrome to all pregnant women].
    van der Maas PJ; Dondorp WJ
    Ned Tijdschr Geneeskd; 2002 Mar; 146(11):501-3. PubMed ID: 11925798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health Council of Netherlands recommendation 'Serum screening for risk assessment of Down syndrome for all women' poorly supported].
    Hamerlynck JV; Knuist M
    Ned Tijdschr Geneeskd; 2001 Oct; 145(42):2014-7. PubMed ID: 11695097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the perspective of midwives involved in offering serum screening for Down's syndrome in Northern Ireland.
    McNeill J; Alderdice F
    J Clin Nurs; 2009 Oct; 18(20):2888-96. PubMed ID: 19619213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women as moral pioneers? Experiences of first trimester antenatal screening.
    Williams C; Sandall J; Lewando-Hundt G; Heyman B; Spencer K; Grellier R
    Soc Sci Med; 2005 Nov; 61(9):1983-92. PubMed ID: 15899542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down's syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women.
    Hwa HL; Yen MF; Lin CL; Ko TM; Hsieh FJ; Chen TH
    J Eval Clin Pract; 2008 Apr; 14(2):191-7. PubMed ID: 18284525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding pregnant women's decision making concerning prenatal screening.
    van den Berg M; Timmermans DR; Knol DL; van Eijk JT; de Smit DJ; van Vugt JM; van der Wal G
    Health Psychol; 2008 Jul; 27(4):430-7. PubMed ID: 18643000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Down's syndrome. Conclusions do not reflect reality.
    Reynolds T
    BMJ; 2002 Jan; 324(7329):111. PubMed ID: 11808522
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for Down's syndrome. Modelling does not predict reality accurately.
    Howe D
    BMJ; 2002 Jan; 324(7329):111-2. PubMed ID: 11808523
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
    Lamlertkittikul S; Chandeying V
    J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The attitude of pregnant women to the possibilities for the prenatal screening and diagnosis of Down's syndrome in the 2nd trimester].
    Dimitrova V; Chernev T; Savova S; Stoianova M
    Akush Ginekol (Sofiia); 2000; 39(1):3-9. PubMed ID: 10826326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome risk estimates demonstrate considerable heterogeneity despite homogeneity of input.
    Reynolds T; Ellis A; Jones R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):464-8. PubMed ID: 15588435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum screening for Down's syndrome. Counselling should emphasise possible outcomes of screening.
    Allaby M
    BMJ; 1994 Nov; 309(6965):1373. PubMed ID: 7866103
    [No Abstract]   [Full Text] [Related]  

  • 16. [Towards a national programme for prenatal screening for Down's syndrome].
    Wildschut HI
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2770-2. PubMed ID: 16385827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using decision analysis to compare policies for antenatal screening for Down's syndrome.
    Fletcher J; Hicks NR; Kay JD; Boyd PA
    BMJ; 1995 Aug; 311(7001):351-6. PubMed ID: 7640539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for Down's syndrome.
    BMJ; 1991 Sep; 303(6804):715-6. PubMed ID: 1833015
    [No Abstract]   [Full Text] [Related]  

  • 19. First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free beta-hCG and pregnancy-associated plasma protein-A assays.
    Spencer K
    Ann Clin Biochem; 2005 Jan; 42(Pt 1):30-40. PubMed ID: 15802030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women and health care professionals' preferences for Down's Syndrome screening tests: a conjoint analysis study.
    Bishop AJ; Marteau TM; Armstrong D; Chitty LS; Longworth L; Buxton MJ; Berlin C
    BJOG; 2004 Aug; 111(8):775-9. PubMed ID: 15270923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.